{
    "Trade/Device Name(s)": [
        "QUANTA Flash\u00ae \u00df2GP1-Domain1",
        "QUANTA Flash\u00ae \u00df2GP1-Domain1 Controls",
        "HemosIL\u00ae AcuStar Anti-\u00df2GPI Domain 1",
        "HemosIL\u00ae AcuStar Anti-\u00df2GPI Domain 1 Controls"
    ],
    "Submitter Information": "Inova Diagnostics, Inc.",
    "510(k) Number": "K152875",
    "Predicate Device Reference 510(k) Number(s)": [
        "K970551"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MSV",
        "JJX"
    ],
    "Summary Letter Date": "September 29, 2015",
    "Summary Letter Received Date": "October 5, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5660",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG autoantibodies to \u00df2GP1-Domain1"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Citrated Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BIO-FLASH instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CIA)"
    ],
    "Methodologies": [
        "Solid phase heterogeneous immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Controls",
        "Calibrators",
        "Reagent Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for QUANTA Flash and HemosIL chemiluminescent immunoassays for the detection of IgG autoantibodies to \u00df2GP1-Domain1 in serum and plasma for antiphospholipid syndrome diagnosis.",
    "Indications for Use Summary": "Semi-quantitative determination of IgG autoantibodies to \u00df2GP1-Domain1 in human serum or citrated plasma, aiding diagnosis of antiphospholipid syndrome in conjunction with clinical and laboratory findings.",
    "fda_folder": "Immunology"
}